Wed, Mar 4, 2015, 11:57 AM EST - U.S. Markets close in 4 hrs 3 mins

Recent

% | $
Quotes you view appear here for quick access.

Flexpoint Sensor Systems Inc. Message Board

falcon_202 36 posts  |  Last Activity: 23 hours ago Member since: Nov 9, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Some News

    by falcon_202 Mar 2, 2015 8:39 AM
    falcon_202 falcon_202 23 hours ago Flag

    MACD cross, other indicators primed and ready. We'll see! Last news evidence of manufacturing process
    starting in one of the bigger projects. What could be a catalyst from here? Large distributor or 3rd party,
    end of the clinical trials for Haemoband, Auto news. Clock is ticking.

  • Reply to

    Some News

    by falcon_202 Mar 2, 2015 8:39 AM
    falcon_202 falcon_202 Mar 2, 2015 10:43 AM Flag

    Oh, and I am fairly certain that the 13,000 figure represents pairs of inserts and this as
    noted is probably a minimum purchase order agreed upon. Looks promising

  • falcon_202 by falcon_202 Mar 2, 2015 8:39 AM Flag

    Manufacturing agreement with Bend Tech with what looks like minimum agreed purchase
    orders for shoes, which I'm sure can be ramped up. I think they said capacity was 100k/month.

  • Reply to

    Two words:

    by falcon_202 Feb 20, 2015 8:14 AM
    falcon_202 falcon_202 Feb 22, 2015 9:46 AM Flag

    Reverse whammy- Bears in control right now with negative techs and lack of enthusiastic buyers for
    three weeks now..

  • falcon_202 by falcon_202 Feb 20, 2015 8:14 AM Flag

    Over-Sold. Stochs oversold. Positive MACD divergence.
    Probably some news update next week.
    Fundamentals unchanged. Three major product launches this year, Mettis and scopes first
    half, and auto ramping up. Fair value now? Almost double. 6 months from now? More. JMO.

  • Reply to

    Under amour has spent $500 mil

    by jal_1961 Feb 6, 2015 8:38 AM
    falcon_202 falcon_202 Feb 6, 2015 11:09 AM Flag

    I don't have an explanation for the drop. Any excuse when the stop drops is as good as another when
    there is no news to explain it, and as far as I know, no change in the fundamentals. Every day is one
    day closer to a deal, signed contract, significant announcement. Is the sky falling? Last time we went
    from .30 to .125 and now .35 to .18. I feels about the same as I did back then at .125-

  • falcon_202 falcon_202 Jan 31, 2015 11:00 AM Flag

    Oh yeah Calvin, and while you're making inquires don't forget to inquire about the auto project launching this year with top auto maker.

  • falcon_202 falcon_202 Jan 31, 2015 9:54 AM Flag

    All Google my friend. Stock down a bit, offers up a bit, and now bashers show up. I wonder if the "smart" money is on the buy side as it has been for a few months now? Fundamentals unchanged. Haemoband will deliver. The product sounds too good and will sell itself IMO.

  • falcon_202 falcon_202 Jan 31, 2015 7:27 AM Flag

    Speaking of Ireland. Forbes number one country for doing business with the U.S. number 14.
    European headquarters for Facebook, Twitter, Google, Linked-In and Medtronic (medical) with a large
    presence, just to name a few.

  • falcon_202 falcon_202 Jan 31, 2015 7:12 AM Flag

    Here we go with the bashers. Haemoband is a private company located in Belfast, Ireland established
    in 2005. They have outsourced the production of their ligatures. Since they are private it is difficult to
    find full company information especially located in Belfast. One reference I noted stated they were on target to do 2 million in sales a few years after establishment in 2005. Another noted approximately 400,000 Euro
    or pounds in cash. They have their Haemoband in multiple countries with at least 15 distributors or more, including Australia, Hong Kong, New Zealand, Europe, U.S. etc. There are multiple medical supply companies offering their product in the U.S. They have made milestone payments to Flexpoint probably to total 100's of thousands after all phases complete. They are in the midst of the clinical trials for the scopes.
    They completed trials for their ligature as well and received US FDA clearance in the past. They had
    a booth at Medica, the largest European Medical Expo.

    They are not Olympus or Flexpoint stock would be 10x. However, they have a track record,
    cash in the bank, a successful product with multiple distribution channels which fit perfectly
    with the Flexpoint scope i.e. marketing to GI physicians dealing with colon issues.
    They have outsourced production and distribution and managed to stay small and probably
    have pretty decent sales as noted above. They may be lean, but probably hungry, competent (GI physician part owner and found) and maybe just what the "doctor" ordered. JMO

  • Reply to

    Today's press report

    by falcon_202 Jan 30, 2015 8:11 AM
    falcon_202 falcon_202 Jan 30, 2015 11:44 AM Flag

    It wouldn't hurt

  • falcon_202 by falcon_202 Jan 30, 2015 8:11 AM Flag

    Veristride using flexpoint sensors in their inserts at the CES. CES product chosen as top
    Innovative product. Breaking into the rehab and medical market. It all adds up. Steve did you say you were buying back the 200k shares you sold yesterday? (LOL)

  • falcon_202 by falcon_202 Jan 29, 2015 6:20 PM Flag

    Early profit taking hammered the stock today without full recovery and many, but not all technicals turned negative. Funky low print allowed for gap close. Impatient investors waiting for news, but fundamentals unchanged.
    Tomorrow may be a day to watch. See if buyers return?

  • Reply to

    The news today

    by falcon_202 Jan 23, 2015 8:18 AM
    falcon_202 falcon_202 Jan 23, 2015 10:21 AM Flag

    There was some previous speculation on this thread that they might have been at the CES this year
    in association with Veristride (a start-up from University of Utah) with inserts for rehab and medical applications. Albeit speculation. Increased exposure while waiting for very significant developments

  • Reply to

    The news today

    by falcon_202 Jan 23, 2015 8:18 AM
    falcon_202 falcon_202 Jan 23, 2015 8:34 AM Flag

    Good find. Under Armour in there too.

  • falcon_202 by falcon_202 Jan 23, 2015 8:18 AM Flag

    While we await some blockbuster news they're keeping us in the loop, hooking up
    with retailers, buyers, distributors for the trainers. Not just running, but golf, skiing, football etc.

  • Reply to

    Tomorrow-

    by stemell Jan 21, 2015 3:01 PM
    falcon_202 falcon_202 Jan 22, 2015 8:26 AM Flag

    If it's not by 8AM usually not that day. With rare exceptions. So I assume next week.

  • Reply to

    Veristride

    by bilozelhi Jan 19, 2015 8:48 AM
    falcon_202 falcon_202 Jan 19, 2015 11:23 AM Flag

    Looked up their website. They have a big push going on for a start up to use foot metrics as in the trainer to
    do rehabilitation. They have a nice marketing presentation. My "guess" is that they are using our sensors
    and inserts since we have "the best technology out there." If true it would provide nice validation,
    and point to an increasing customer base for our technology. That's my guess.

  • Reply to

    Falc,Stevie,Bilo,Jal,

    by stemell Jan 16, 2015 3:19 PM
    falcon_202 falcon_202 Jan 16, 2015 8:25 PM Flag

    Bullish triple top breakout above .30 with print at .32. Going back to 2014 and pre 2012. P&F chart.
    Suggests some news next week as mentioned previously. Too soon for Harmoband trial completion, too soon for auto so maybe shoes or new project. "Three horses chomping at the bit." I liked that.

  • Reply to

    Bid-

    by stemell Jan 15, 2015 11:35 AM
    falcon_202 falcon_202 Jan 16, 2015 11:41 AM Flag

    Stock thru triple top of .227. First upside target on upside move .30. A move today, might mean some
    news next week. We'll see.

FLXT.OB
0.1699-0.0001(-0.06%)Oct 30 2:14 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.